期刊
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
卷 31, 期 4, 页码 363-371出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/jir.2010.0083
关键词
-
资金
- National Sciences and Engineering Research Council of Canada
- Canada Foundation for Innovation
- Ministry of Higher Education, Malaysia
- Universiti Sains Malaysia
- Canadian Institutes of Health Research
Interleukin (IL)-23 plays a critical role in the development of the T helper (Th) cell response and is responsible for the maintenance of the IL-17 producing subset of Th cells, Th17. IL-23 is a heterodimeric cytokine composed of IL-23p19 and IL-12p40 subunits, and the signaling pathway for IL-23 involves 2 receptor chains: IL-12R beta 1 and IL-23R alpha. The IL-23 receptor complex is expressed on a number of cells, including natural killer cells, monocytes, macrophages, dendritic cells, and CD4 T cells. Currently, the molecular mechanisms governing expression of the IL-23 receptor chains, IL-23R alpha and IL-12R beta 1, are not well understood. Our results show that IL-23 induces upregulation of IL-23R alpha and IL-12R beta 1 expression in human CD4 T cells. Further, we demonstrate that inhibition of the Janus kinase/signal transducer and activation of transcription (JAK/STAT) pathway by SD-1029, a JAK2 inhibitor, 5'-deoxy-5'-(methylthio) adenosine, a STAT1 inhibitor, and STAT3 VII, a STAT3 inhibitor, were able to block IL-23-induced expression of IL-23 receptor subunits in the human SUPT-1 T cell line and in primary CD4 human T cells. Taken together, our results suggest a positive feedback regulation of the IL-23 receptor via IL-23-mediated activation of the JAK/STAT pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据